Market Overview:
The global DTC genetic testing market is expected to grow at a CAGR of 16.5% during the forecast period from 2018 to 2030. The market is segmented on the basis of type, application, and region. On the basis of type, the market is segmented into targeted analysis, single nucleotide polymorphism (SNP) chips, and whole genome sequencing (WGS). The SNP chips segment is expected to grow at a CAGR of 17.8% during the forecast period from 2018 to 2030. On the basis of application, the market is divided into carrier testing, predictive testing, ancestry and relationship testing, nutrigenomics testing,, and others segments.
Product Definition:
DTC genetic testing is the process of directly testing a patient's DNA for specific gene mutations. This type of test can be used to diagnose or rule out genetic conditions, and can also be used to help guide decisions about medical care. DTC genetic tests are available for a variety of conditions, including cancer, heart disease, and Alzheimer's disease.
Targeted Analysis:
Targeted analysis is a genetic test that helps in determining the likely areas for drug therapy to treat a certain disease. It also helps in predicting the possible side effects of medication and their severity. This technique has gained significant traction over recent years owing to its accuracy, cost-effectiveness, and rapid results.
Single Nucleotide Polymorphism (SNP) Chips:
SNP chips are small pieces of DNA that can be attached to a larger piece of DNA. They are used in genetic testing for determining variations between members of a species, such as humans and dogs. SNP chips allow rapid processing and provide results within 15 minutes.
Application Insights:
Carrier testing accounted for the largest revenue share in 2016 owing to its high usage in prenatal genetic testing. The rising number of affected individuals and increasing awareness about carrier screening are factors contributing towards the segment growth. On the other hand, adoption of whole genome sequencing is highest among patients seeking information related to cancer susceptibility.
Predictive testing is anticipated to witness lucrative growth over the forecast period due to its growing adoption by companies offering predictive medicine. For instance, In November 2017, DNAFit partnered with Longeveron LLC and Myriad Genetics Incorporated to offer their respective myDNA tests through their myDx+ product line across all major markets including United States, Canada, Germany and China. Such initiatives by prominent players are expected drive industry expansion over next few years.
Regional Analysis:
North America dominated the global DTC genetic testing market in 2017. This is due to the presence of well-established healthcare infrastructure, high adoption rate of advanced technologies, and a large number of companies offering such tests. Moreover, an increase in R&D investments by companies for development of novel tests will propel the growth further.
Asia Pacific is expected to grow at a lucrative rate during the forecast period owing to increasing awareness about available genetic tests among people as well as rapid economic growth in this region which has led it become one amongst top exporters across various sectors including medical services & supplies globally.
Growth Factors:
- Increasing demand for personalized medicine: The global market for personalized medicine is expected to grow at a CAGR of 16.8% from 2016 to 2021. This is primarily due to the increasing incidence of chronic diseases, growing awareness about the benefits of personalized medicine, and technological advancements in the field of genomics. DTC genetic testing can help identify an individual’s risk factors for various chronic diseases and enable them to take preventive measures accordingly.
- Growing demand for companion diagnostics: Companion diagnostics are tests used along with targeted therapies to determine whether a patient is likely to respond positively or negatively to a particular drug therapy. They are also used as biomarkers for early detection and treatment monitoring of cancer patients. The global market for companion diagnostics is expected grow at a CAGR of 18% from 2016-2021 owing to the increasing prevalence of cancer and other chronic diseases, growing adoption rates of precision medicines, and technological advancements in this field.. DTC genetic testing can play an important role in identifying individuals who would benefit from using specific drugs as part of their therapeutic regimen
Scope Of The Report
Report Attributes
Report Details
Report Title
DTC Genetic Testing Market Research Report
By Type
Targeted Analysis, Single Nucleotide Polymorphism (SNP) Chips, Whole Genome Sequencing (WGS)
By Application
Carrier Testing, Predictive Testing, Ancestry and Relationship Testing, Nutrigenomics Testing, Others
By Companies
23andMe, Ancestry, Color, EasyDNA, Family Tree DNA（Gene by Gene）, Full Genomes, Genesis HealthCare, Helix, Identigene, Karmagenes, Living DNA, MapMyGenome, MyHeritage, Pathway Genomics
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
186
Number of Tables & Figures
131
Customization Available
Yes, the report can be customized as per your need.
Global DTC Genetic Testing Market Report Segments:
The global DTC Genetic Testing market is segmented on the basis of:
Types
Targeted Analysis, Single Nucleotide Polymorphism (SNP) Chips, Whole Genome Sequencing (WGS)
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Carrier Testing, Predictive Testing, Ancestry and Relationship Testing, Nutrigenomics Testing, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- 23andMe
- Ancestry
- Color
- EasyDNA
- Family Tree DNA（Gene by Gene）
- Full Genomes
- Genesis HealthCare
- Helix
- Identigene
- Karmagenes
- Living DNA
- MapMyGenome
- MyHeritage
- Pathway Genomics
Highlights of The DTC Genetic Testing Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Targeted Analysis
- Single Nucleotide Polymorphism (SNP) Chips
- Whole Genome Sequencing (WGS)
- By Application:
- Carrier Testing
- Predictive Testing
- Ancestry and Relationship Testing
- Nutrigenomics Testing
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the DTC Genetic Testing Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
DTC genetic testing is a type of genetic test that can be used to determine if a person has inherited a gene mutation from one of their parents. This type of test is often used to diagnose conditions such as cancer, heart disease, and other serious medical conditions.
Some of the key players operating in the dtc genetic testing market are 23andMe, Ancestry, Color, EasyDNA, Family Tree DNA（Gene by Gene）, Full Genomes, Genesis HealthCare, Helix, Identigene, Karmagenes, Living DNA, MapMyGenome, MyHeritage, Pathway Genomics.
The dtc genetic testing market is expected to register a CAGR of 16.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 DTC Genetic Testing Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 DTC Genetic Testing Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 DTC Genetic Testing Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the DTC Genetic Testing Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global DTC Genetic Testing Market Size & Forecast, 2018-2028
4.5.1 DTC Genetic Testing Market Size and Y-o-Y Growth
4.5.2 DTC Genetic Testing Market Absolute $ Opportunity
Chapter 5 Global DTC Genetic Testing Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 DTC Genetic Testing Market Size Forecast by Type
5.2.1 Targeted Analysis
5.2.2 Single Nucleotide Polymorphism (SNP) Chips
5.2.3 Whole Genome Sequencing (WGS)
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global DTC Genetic Testing Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 DTC Genetic Testing Market Size Forecast by Applications
6.2.1 Carrier Testing
6.2.2 Predictive Testing
6.2.3 Ancestry and Relationship Testing
6.2.4 Nutrigenomics Testing
6.2.5 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global DTC Genetic Testing Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 DTC Genetic Testing Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America DTC Genetic Testing Analysis and Forecast
9.1 Introduction
9.2 North America DTC Genetic Testing Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America DTC Genetic Testing Market Size Forecast by Type
9.6.1 Targeted Analysis
9.6.2 Single Nucleotide Polymorphism (SNP) Chips
9.6.3 Whole Genome Sequencing (WGS)
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America DTC Genetic Testing Market Size Forecast by Applications
9.10.1 Carrier Testing
9.10.2 Predictive Testing
9.10.3 Ancestry and Relationship Testing
9.10.4 Nutrigenomics Testing
9.10.5 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe DTC Genetic Testing Analysis and Forecast
10.1 Introduction
10.2 Europe DTC Genetic Testing Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe DTC Genetic Testing Market Size Forecast by Type
10.6.1 Targeted Analysis
10.6.2 Single Nucleotide Polymorphism (SNP) Chips
10.6.3 Whole Genome Sequencing (WGS)
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe DTC Genetic Testing Market Size Forecast by Applications
10.10.1 Carrier Testing
10.10.2 Predictive Testing
10.10.3 Ancestry and Relationship Testing
10.10.4 Nutrigenomics Testing
10.10.5 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific DTC Genetic Testing Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific DTC Genetic Testing Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific DTC Genetic Testing Market Size Forecast by Type
11.6.1 Targeted Analysis
11.6.2 Single Nucleotide Polymorphism (SNP) Chips
11.6.3 Whole Genome Sequencing (WGS)
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific DTC Genetic Testing Market Size Forecast by Applications
11.10.1 Carrier Testing
11.10.2 Predictive Testing
11.10.3 Ancestry and Relationship Testing
11.10.4 Nutrigenomics Testing
11.10.5 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America DTC Genetic Testing Analysis and Forecast
12.1 Introduction
12.2 Latin America DTC Genetic Testing Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America DTC Genetic Testing Market Size Forecast by Type
12.6.1 Targeted Analysis
12.6.2 Single Nucleotide Polymorphism (SNP) Chips
12.6.3 Whole Genome Sequencing (WGS)
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America DTC Genetic Testing Market Size Forecast by Applications
12.10.1 Carrier Testing
12.10.2 Predictive Testing
12.10.3 Ancestry and Relationship Testing
12.10.4 Nutrigenomics Testing
12.10.5 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) DTC Genetic Testing Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) DTC Genetic Testing Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) DTC Genetic Testing Market Size Forecast by Type
13.6.1 Targeted Analysis
13.6.2 Single Nucleotide Polymorphism (SNP) Chips
13.6.3 Whole Genome Sequencing (WGS)
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) DTC Genetic Testing Market Size Forecast by Applications
13.10.1 Carrier Testing
13.10.2 Predictive Testing
13.10.3 Ancestry and Relationship Testing
13.10.4 Nutrigenomics Testing
13.10.5 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 DTC Genetic Testing Market: Competitive Dashboard
14.2 Global DTC Genetic Testing Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 23andMe
14.3.2 Ancestry
14.3.3 Color
14.3.4 EasyDNA
14.3.5 Family Tree DNA（Gene by Gene）
14.3.6 Full Genomes
14.3.7 Genesis HealthCare
14.3.8 Helix
14.3.9 Identigene
14.3.10 Karmagenes
14.3.11 Living DNA
14.3.12 MapMyGenome
14.3.13 MyHeritage
14.3.14 Pathway Genomics
